Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

February 14, 2023

Study Completion Date

October 8, 2024

Conditions
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

BIO89-100

Subcutaneous injection

DRUG

Placebo

Subcutaneous injection

Trial Locations (89)

10033

89bio Clinical Study Site, New York

20110

89bio Clinical Study Site, Manassas

20770

89bio Clinical Study Site, Greenbelt

21061

89bio Clinical Study Site, Glen Burnie

23235

89bio Clinical Study Site, Richmond

23249

89bio Clinical Study Site, Richmond

24014

89bio Clinical Study Site, Roanoke

28027

89bio Clinical Study Site, Concord

29485

89bio Clinical Study Site, Summerville

29646

89bio Clinical Study Site, Greenwood

30328

89bio Clinical Study Site, Sandy Springs

30607

89bio Clinical Study Site, Athens

32127

89bio Clinical Study Site, Maitland

89bio Clinical Study Site, Port Orange

32940

89bio Clinical Study Site, Viera

33014

89bio Clinical Study Site, Miami

33016

89bio Clinical Study Site, Miami Lakes

33147

89bio Clinical Study Site, Miami

33157

89bio Clinical Study Site, Miami

89bio Clinical Study Site, Palmetto Bay

33472

89bio Clinical Study Site, Boynton Beach

33781

89bio Clinical Study Site, Pinellas Park

33805

89bio Clinical Study Site, Lakeland

33912

89bio Clinical Study Site, Fort Myers

34208

89bio Clinical Study Site, Bradenton

34240

89bio Clinical Study Site, Sarasota

34471

89bio Clinical Study Site, Ocala

35209

89bio Clinical Study Site, Birmingham

35211

89bio Clinical Study Site, Birmingham

35758

89bio Clinical Study Site, Madison

35976

89bio Clinical Study Site, Guntersville

36305

89bio Clinical Study Site, Dothan

37076

89bio Clinical Study Site, Hermitage

37411

89bio Clinical Study Site, Chattanooga

37421

89bio Clinical Study Site, Chattanooga

43210

89bio Clinical Study Site, Columbus

44145

89bio Clinical Study Site, Westlake

45066

89bio Clinical Study Site, Springboro

45414

89bio Clinical Study Site, Dayton

46635

89bio Clinical Study Site, South Bend

47150

89bio Clinical Study Site, New Albany

52246

89bio Clinical Study Site, Iowa City

63033

89bio Clinical Study Site, St Louis

66606

89bio Clinical Study Site, Topeka

71103

89bio Clinical Study Site, Shreveport

71201

89bio Clinical Study Site, Monroe

72205

89bio Clinical Study Site, Little Rock

75044

89bio Clinical Study Site, Garland

75234

89bio Clinical Study Site, Dallas

75246

89bio Clinical Study Site, Dallas

76104

89bio Clinical Study Site, Fort Worth

76301

89bio Clinical Study Site, Wichita Falls

76710

89bio Clinical Study Site, Waco

76712

89bio Clinical Study Site, Waco

77030

89bio Clinical Study Site, Houston

77099

89bio Clinical Study Site, Houston

77702

89bio Clinical Study Site, Beaumont

78209

89bio Clinical Study Site, San Antonio

78215

89bio Clinical Study Site, San Antonio

78539

89bio Clinical Study Site, Edinburg

80113

89bio Clinical Study Site, Englewood

84092

89bio Clinical Study Site, Sandy City

84405

89bio Clinical Study Site, Ogden

85036

89bio Clinical Study Site, Glendale

85224

89bio Clinical Study Site, Chandler

85306

89bio Clinical Study Site, Peoria

85741

89bio Clinical Study Site, Tucson

89119

89bio Clinical Study Site, Las Vegas

89121

89bio Clinical Study Site, Las Vegas

90255

89bio Clinical Study Site, Huntington Park

90808

89bio Clinical Study Site, Long Beach

91402

89bio Clinical Study Site, Panorama City

91911

89bio Clinical Study Site, Chula Vista

92377

89bio Clinical Study Site, Rialto

92704

89bio Clinical Study Site, Santa Ana

92866

89bio Clinical Study Site, Orange

98105

89bio Clinical Study Site, Seattle

99202

89bio Clinical Study Site, Spokane

85712-4044

89bio Clinical Study Site, Tucson

85712-4046

89bio Clinical Study Site, Tucson

72205-6414

89bio Clinical Study Site, Little Rock

70072-3151

89bio Clinical Study Site, Marrero

70072-3155

89bio Clinical Study Site, Marrero

07932

89bio Clinical Study Site, Florham Park

78757-8051

89bio Clinical Study Site, Austin

78757-8059

89bio Clinical Study Site, Austin

78229-4801

89bio Clinical Study Site, San Antonio

78229-5069

89bio Clinical Study Site, San Antonio

00927

89bio Clinical Study Site, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

89bio, Inc.

INDUSTRY

NCT04929483 - Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter